Johnson & johnson earnings -

Johnson & Johnson Earnings


In this recap of Johnson & Johnson's latest earnings report, you can learn how the company's consumer, pharmaceutical and medical devices businesses performed in the second quarter of 2018. [Operator instructions] This call is being recorded Operator. Johnson & Johnson said adjusted earnings for the three months ending johnson & johnson earnings in March were pegged at $2.59 cents per share, up 12.6% from the same period last year and well ahead of the Street consensus. Notably, the Whisper number. Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices. Q4. Johnson & Johnson (JNJ Quick Quote JNJ - Free Report) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.31 per share. The company detailed the sales figures in its first-quarter earnings report, which noted that Johnson & Johnson saw overall quarterly growth of 8%. Good morning and welcome to Johnson & Johnson's first-quarter 2021 earnings conference call.


Find the latest Earnings Report Date for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com Good morning and welcome to Johnson & Johnson's first-quarter 2021 earnings conference call. Johnson & Johnson EPS for the quarter ending March 31, 2021 was $2.32, a 6.91% increase year-over-year. Learn how Johnson & Johnson’s consumer, pharmaceutical and medical devices businesses performed in the first quarter of 2021 in this recap of the company’s latest earnings report. Johnson & Johnson First Quarter 2021 Earnings Call and Webcast Johnson & Johnson to Participate in the BofA Securities Virtual 2021 Healthcare Conference Register for Webcast: Raymond James 42 nd Annual Institutional Investors Conference. @BerkeleyJr. Q2 johnson & johnson earnings 2018 (Jun 2018) EPS of $2.10 beat by $0.03 Revenue of $20.83B (10.57% YoY) beat by $439.72M.


Johnson & Johnson reports $100 million in quarterly sales from Covid johnson & johnson earnings vaccine Published Tue, Apr 20 2021 6:49 AM EDT Updated Tue, Apr 20 2021 12:27 PM EDT Berkeley Lovelace Jr. Johnson & Johnson EPS for the twelve months ending March 31, 2021 was $5.66, a 11.7% decline year-over-year. The earnings press release offered no new details on the current pause that has suspended administration of the company. Meanwhile, the Earnings Whisper number stands at $2.41 per share. Johnson & Johnson 2020 annual EPS was $5.51, a 2.13% decline from 2019 Q2 2018 (Jun 2018) EPS of $2.10 beat by $0.03 Revenue of $20.83B (10.57% YoY) beat by $439.72M. Four analysts surveyed by Zacks expected $21.82 billion.


ADD YOUR COMMENT

Your email address will not be published. Required fields are marked *